DG Win 5/10 Tablets
July 21, 2025
Fenzet Tablets
July 21, 2025DG Win V Tablets
Dapagliflozin 10 mg + Vildagliptin 100 mg
DG Win V combines Dapagliflozin and Vildagliptin to deliver superior glycemic control with added cardiovascular, weight, and BP benefits.
Key Components & Benefits
-
Safer and sustained glycemic control
-
Delivers extraglycemic benefits:
-
Reduces body weight
-
Lowers systolic blood pressure (SBP)
-
-
Reduces risk of cardiovascular events
Mechanism of Action
Dapagliflozin – SGLT2 inhibitor:
-
Reduces reabsorption of glucose and sodium
-
Increases urinary glucose excretion
-
Improves HbA1c levels and supports weight loss
- Vildagliptin: DPP-4 Inhibitor
- Inhibits DPP-4
- Increases Incretin Levels
- Enhances Insulin Secretion
- Supresses Glucagon Secretion.
- Improves Glycemic Control.
- Improves Glucose Tolerance.
Also Available
DG Win M Tablets
(Dapagliflozin 10 mg + Metformin ER 500 mg)
